Seeing Is Believing
Currently out of the existing stock ratings of Steve Byrne, 32 are a SELL (20%), 75 are a BUY (46.88%), 53 are a HOLD (33.13%).
Analyst Steve Byrne works at BAML with a stock forecast success ratio of 65.38% fulfilled within 212.66 days on average.
Steve Byrne’s has documented 484 price targets and ratings displayed on 32 stocks. The coverage is on Basic Materials, Consumer Defensive, Healthcare sectors.
Most recent stock forecast was given on APD, Air Products and Chemicals at 01-May-2024.
Analyst best performing recommendations are on PCRX (PACIRA PHARMACEUTICALS).
The best stock recommendation documented was for GPRE (GREEN PLAINS RENEWABLE ENERGY) at 10/24/2022. The price target of $35 was fulfilled within 17 days with a profit of $7.74 (28.39%) receiving and performance score of 16.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
128
$-0.1 (-0.08%)
112
3 days ago
20/22 (90.91%)
$2.7 (2.15%)
198
Buy
145
$16.9 (13.19%)
135
24 days ago
13/18 (72.22%)
$14.69 (11.27%)
224
Sell
81
$-47.1 (-36.77%)
90
1 months 24 days ago
4/7 (57.14%)
$-43.75 (-35.07%)
240
Buy
159
$30.9 (24.12%)
178
1 months 28 days ago
20/29 (68.97%)
$39.41 (32.95%)
539
Hold
130
2 months 4 days ago
6/11 (54.55%)
$7.41 (6.04%)
102
Which stock is Steve Byrne is most bullish on?
Which stock is Steve Byrne is most reserved on?
What Year was the first public recommendation made by Steve Byrne?